Also. . .
Irish drug maker Elan Corp. said that it agreed to acquire Neurex Corp., a Menlo Park-based drug maker specializing in pain medication, in a stock swap worth $700 million. Elan, based in Dublin, has spent $2 billion making acquisitions in the last two years. The company is branching into a new area with the acquisition of Neurex and its drugs to treat pain.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
